FDA approves diabetes drug Afrezza
WASHINGTON — Afrezza, an inhaled insulin powder meant to treat diabetes patients, was approved Friday by the Food and Drug Administration.
The powder — manufactured by MannKind Corp. — is an inhalable dose of insulin that can be taken before meals to control blood sugar for patients with Type 1 and Type 2 diabetes. The drug is not meant to replace long-acting insulin in patients with Type 1 diabetes.
Along with approval, the FDA is requiring more clinical trials to test whether Afrezza is safe and effective for pediatric patients. Additionally, the approval comes with a plan to let doctors and pharmacists know that the drug poses a risk of acute bronchospasm when used by patients with asthma or Chronic Obstructive Pulmonary Disease.
Otherhood: Rewriting the fairytale
Women today play a dynamic role in society, and brands and marketers — including those within the retail pharmacy space — are tirelessly working to earn her trust and loyalty, as she often makes most of the healthcare decisions for her family. While reaching “moms” is no doubt important, new research suggests that brands and marketers may be missing a tremendous opportunity among those women who are rewriting the fairy tale.
“Otherhood” consists of women from many different backgrounds: she could be single and never married, living with a partner or a same-sex partner, married with no children, separated, divorced or widowed. No matter her circumstances, she accounts for 47% of women of childbearing age, and she has significant buying power.
Fascinated by the insights revealed in the book, “Otherhood,” by author Melanie Notkin, consumer PR and social media agency DeVries Global set out to partner with Notkin and take a closer look at these women through a recently released study called “Shades
The insights revealed in the study, conducted in late 2013 among 1,000 non-moms and 1,000 moms across the country, debunk the myths and stereotypes about this influential group of women and highlight opportunities to target their needs.
NABP, ADIWG create educational video to combat Rx drug abuse
The National Association of Boards of Pharmacy and the Anti-Diversion Industry Working Group created an educational video for pharmacists to help better combat prescription drug abuse. The video, titled "Red Flags," was released at NABP's 110th Annual Meeting.